DALLAS, April 4, 2006 (PRIMEZONE) -- Kathy Lardie, Director of Sales for TalkingStocks.com, announced today that the website has initiated coverage of Neuroscience Therapy Corporation (Pink Sheets:NPYC). Neuroscience Therapy Corporation holds the rights to a new and innovative technology to relieve pain based upon two thousand year old medical practices with the incorporation of modern day micro chip technology. The product portfolio presently consists of two complementary products: the P-Stim Electro Stimulation device and the Multi-Point stylus. It is capable of relieving pain almost anywhere in the body and has the potential to treat many other clinical conditions. This device has been used on several thousand patients, in Europe, with remarkable results, and has no known side effects.
P-Stim is a miniaturized electro-stimulation device that operates on the principle of auricular (ear) acupuncture. Micro-processor controlled, it generates a low frequency electrical pulse which is transmitted to the peripheral nerve endings in the ear. This stimulation results in the release of endorphins which are substances that have an analgesic or pain relieving effect. P-Stim is placed behind the ear with an adhesive and the pulses are transmitted via stimulating needles in the ear muscle to the nerve endings in this muscle. P-Stim allows a continuous therapy over several days.
To view the TalkingStocks.com profile for Neuroscience Therapy Corporation, please visit: http://www.talkingstocks.com/p/npyc/
About Neuroscience Therapy Corporation:
Neuroscience Therapy Corporation's operations are located in Southern California. It holds the rights to a new, safe and innovative technology to relieve pain. Its product portfolio consists of two complementary products: the P-Stim(TM) Electro Stimulation Device and the Multi-Point(TM) Stylus. These products have no known side effects, unlike many pharmaceutical pain relievers. The neurostimulation market is in its infancy and could reach several billion dollars in sales. The Company is working toward being a leader in this market. For more information about Neuroscience Therapy Corp., visit: www.neurosciencetherapy.com.
About TalkingStocks.com
TalkingStocks.com is a leading destination for those seeking information on small cap and microcap companies. The website feature companies in Profile Campaigns, Key Executive Interviews, email alerts and special reports authored by our financial writers. The web site set the standard for communication with investors. To feature a company or to get more information, please contact our Director of Sales, Kathy Lardie, for more information (Telephone: 469-252-3036; Email: Kathy@TalkingStocks.com).
Legal Notice Regarding Forward Looking Statements
The statements in this press release that relate to the Company's expectations with regard to the future impact on the Company's results are forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this document may also contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results.
Disclosure: Talking Stocks LLC was compensated fifty thousand free trading shares from a non-controlling third party for profile coverage. Talking Stocks LLC is not a registered investment advisers or broker/dealers. Talking Stocks LLC makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.